TrialCancer science2022
Two-year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemia.
Naohiro Sekiguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled ittrialcites it
TrialCancer science2022
Naohiro Sekiguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.